KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nova (NVMI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Nova (NVMI) over the last 17 years, with Q3 2025 value amounting to $6.57.

  • Nova's Shares Outstanding (Weighted Average) rose 4344.98% to $6.57 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.57, marking a year-over-year increase of 4344.98%. This contributed to the annual value of $6.31 for FY2024, which is 3340.38% up from last year.
  • Per Nova's latest filing, its Shares Outstanding (Weighted Average) stood at $6.57 for Q3 2025, which was up 4344.98% from $4.54 recorded in Q2 2025.
  • Over the past 5 years, Nova's Shares Outstanding (Weighted Average) peaked at $6.57 during Q3 2025, and registered a low of $0.62 during Q1 2021.
  • In the last 5 years, Nova's Shares Outstanding (Weighted Average) had a median value of $2.83 in 2024 and averaged $3.15.
  • As far as peak fluctuations go, Nova's Shares Outstanding (Weighted Average) soared by 10491.8% in 2021, and later crashed by 663.9% in 2023.
  • Over the past 5 years, Nova's Shares Outstanding (Weighted Average) (Quarter) stood at $3.28 in 2021, then surged by 49.09% to $4.89 in 2022, then fell by 3.27% to $4.73 in 2023, then soared by 33.4% to $6.31 in 2024, then rose by 4.12% to $6.57 in 2025.
  • Its last three reported values are $6.57 in Q3 2025, $4.54 for Q2 2025, and $2.22 during Q1 2025.